MRNS - Why Shares of iBio Marinus Pharmaceuticals and Arcturus Therapeutics All Crashed on Tuesday
On Tuesday, shares of up-and-coming biotechs Marinus Pharmaceuticals (NASDAQ: MRNS) , iBio (NYSEMKT: IBIO) , and Arcturus Therapeutics Holdings (NASDAQ: ARCT) fell by 12%, 13%, and 19%, respectively.
One common catalyst seems to be the secondary-share issues announced by all three companies, although another important factor may be at play.
Image source: Getty Images.
For further details see:
Why Shares of iBio, Marinus Pharmaceuticals, and Arcturus Therapeutics All Crashed on Tuesday